Petra Acquisition, Inc.
Status: Deal Closed
U=S+W
W=S@11.5
| IPO Proceeds, $M | $72.78M |
|---|---|
| IPO Date | Oct 8, 2020 |
| CEO | Andreas Typaldos |
| Left Lead | LifeSci Capital |
| IPO Cash in Trust | 101.3% |
| SPAC Tenor | 12+1+1+1 |
| IPO Sector | Healthcare |
| IPO Geography | Global |
| Target Company | Revelation Biosciences, Inc. |
| Deal Announced | Aug 30, 2021 |
| Deal Size, $M | $127.70M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Jan 6, 2022 |
| Amendment Vote | TBD |
| Closing Date | Jan 10, 2022 |
Formerly PAIC
REVB
REVBW
| Price | $0.76 $0.00 |
|---|---|
| Last closing price | $0.76 |
| H/L, today | $0.76 / $0.79 |
| H/L, 52-week | $0.56 / $11.39 |
| Volume, today | 23,793 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Petra Acquisition, Inc.:
- Structure and cap table
- 7 directors & officers
- 30 filings and events
- 4 underwriters
- 2 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Andreas Typaldos | 74 | Chairman, CEO and Secretary |
| Sean Fitzpatrick | 51 | CFO and Director |
| David Dobkin | 41 | Director |
| Anthony Hayes | 52 | Director |
| Robert Nicholson | 55 | Director |
| Barry Dennis | 55 | Director |
| William H. Carson | 73 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| LifeSci Capital | Joint BR | 2,000,000 | units |
| Ladenburg Thalmann | Joint BR | 2,450,000 | |
| Northland Capital Markets | 1,400,000 | ||
| Ingalls & Snyder | 1,150,000 | ||
| 7,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| BCMA | 4.00 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.